Claims for Patent: 5,233,034

Summary for Patent: 5,233,034

Title:	Process for the purification of hemin, a novel derivative and process for its preparation
Abstract:	Process for the purification of hemin by dissolving raw hemin into 1,3-dimethyl-2-imidazolidinone (DMI), the mixture is allowed to cool in order to crystallize the hemin in the form of a 1:3-adduct of hemin and DMI, whereafter the adduct obtained is split by mixing the same with warm water, a lower alcohol or in a mixture thereof, or by heating in a vacuum, and the liberated hemin is recovered. The invention also concerns a novel hemin derivative, that is the 1:3-adduct of hemin and DMI, and a process for its preparation.
Inventor(s):	Toikka; Jarmo (Turku, FI)
Assignee:	Huhtamaki Oy (Turku, FI)
Application Number:	07/773,873
Patent Claims:	1. A process for the purification of hemin, comprising the steps of: dissolving raw hemin in 1,3-dimethyl-2-imidazolidinone (DMI) while heating to form a mixture thereof; allowing the mixture to cool in order to crystallize a 1:3-adduct of hemin and DMI; and treating the adduct by splitting the same and recovering the liberated hemin. 2. The process of claim 1, wherein the raw hemin is dissolved in an amount by weight of DMI which is 5 to 10 times the weight of hemin. 3. The process of claim 2, wherein the raw hemin is dissolved in an amount by weight of DMI which is 8 to 10 times the weight of hemin. 4. The process of claim 1, wherein the mixture of hemin and DMI is allowed to cool to a temperature between 8.degree. C. and room temperature in order to crystallize the hemin-DMI adduct. 5. The process of claim 4, wherein the adduct of hemin and DMI is crystallized at a temperature of about 10.degree. C. 6. The process of claim 1, wherein the adduct is treated in warm water, a lower alcohol, or a mixture thereof. 7. The process of claim 6, wherein the adduct is treated in an aqueous lower alcohol. 8. The process of claim 7, wherein the aqueous lower alcohol solution is 70% ethanol. 9. The process of claim 7, wherein the adduct is treated by heating to a temperature above 50.degree. C. 10. The process of claim 1, wherein the adduct is treated at a temperature of 60.degree. to 70.degree. C. 11. The process of claim 1, wherein the adduct is treated by heating in a vacuum. 12. The process of claim 11, wherein the adduct is treated by heating in the vacuum at 105.degree. C. 13. A process for the preparation of a 1:3-adduct of hemin and 1,3-dimethyl-2-imidazolidinone (DMI) comprisng the steps of: dissolving raw hemin in DMI while heating to obtain a mixture thereof; allowing the mixture to cool in order to crystallize a 1:3-adduct of hemin and DMI; and recovering and drying the adduct at a temperature not higher than 50.degree. C.

Details for Patent 5,233,034

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	PANHEMATIN	hemin for injection	For Injection	101246	07/20/1983		2010-08-03